Cigna Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Brian C. Evanko
- Full Time Employees
- 66,685
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- 900 Cottage Grove Road Bloomfield CT United States of America 06002
- IPO Date
- Mar 31, 1982
- CIK
- 0001739940
- Website
- thecignagroup.com
- Similar Companies
- Business
- The Cigna Group operates as a global health services company primarily in the United States, with significant international operations across more than 30 countries. Founded in 1792 and headquartered in Bloomfield, Connecticut, Cigna delivers a comprehensive range of health insurance and related services. Its core offerings include medical, dental, behavioral health, pharmacy benefits management, specialty pharmacy services, vision, and supplemental insurance products. The company serves both insured and self-insured customers through Cigna Healthcare, which includes U.S. Commercial, U.S. Government, and International Health segments. Cigna Healthcare's product portfolio incorporates Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans. Additionally, Cigna provides integrated behavioral, medical, and pharmacy management solutions, health advocacy programs, care management, and advanced analytics through its Evernorth Health Services segment. Evernorth encompasses coordinated and point solution health services including home delivery pharmacy, specialty pharmaceutical distribution, care delivery, and benefit management for health plans, employers, government organizations, and healthcare providers. Recent major changes at Cigna include the 2023 rebranding of its holding company to The Cigna Group, with its health benefits provider business unit named Cigna Healthcare and its health services unit renamed Evernorth Health Services. In early 2024, Cigna agreed to sell its Medicare Advantage, Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC) in a transaction valued at approximately $3.7 billion, which closed in March 2025. This strategic move marks Cigna’s exit from the Medicare Advantage space to refocus on other growth areas. Leadership changes in January 2024 appointed Brian Evanko as President and CEO of Cigna Healthcare to unify and accelerate innovation and growth across the healthcare businesses. Cigna continues to emphasize reducing member healthcare costs and improving patient access by simplifying prior authorizations and expanding advocacy for complex conditions. The company also retains a strong presence in pharmacy benefits management through Express Scripts, which remains a significant profit generator. Cigna targets a broad range of customers including employers, union groups, Medicare and Medicaid beneficiaries, individuals, and multinational corporations, supported by a global footprint extending across more than 30 countries. The company’s product suite is designed to deliver integrated healthcare solutions, combining insurance coverage with care management and pharmacy services to improve health outcomes and control costs. Cigna distributes its products through brokers, consultants, direct employer relationships, and public and private exchanges. Overall, The Cigna Group is a comprehensive healthcare services provider offering multi-faceted insurance products and health management solutions, with a strategic focus on growth through innovation, customer-centric care, and operational efficiency within its core U.S. and international markets. Its recent divestiture of Medicare Advantage businesses and leadership restructuring reflect a significant strategic realignment aimed at strengthening its health services and integrated medical offerings.
Why Cigna (CI) is a Top Value Stock for the Long-Term
Here's Why Cigna (CI) is a Strong Growth Stock
Cigna Group $CI Stock Holdings Lifted by Bank of America Corp DE
Cigna's Valuation Gap Still Stands Out
Cigna Group Q2 Earnings Call Highlights
CI Q2 Earnings Beat Estimates on Cigna Healthcare Strength
Cigna Expects Lower Growth in Popular GLP-1 Drug Prescriptions
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
The Cigna Group (CI) Q2 2026 Earnings Call Transcript
Cigna (CI) Q2 Earnings and Revenues Top Estimates
As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit
Cigna Group Lifts Outlook, Logs Higher Profit on Growth Across Businesses
Cigna raises annual profit forecast on strength in health services unit
The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook
CI Global Asset Management Announces Risk Rating Changes for Two Funds
Cetera Investment Advisers Has $22.26 Million Stake in Cigna Group $CI
Will Declining Medical Customers Affect Cigna's Q2 Earnings?
Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?
Seeking Clues to Cigna (CI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Gabelli Funds LLC Sells 3,060 Shares of Cigna Group $CI